Holen Sie sich die Stockscreener-App
34.71
7.64%
-2.87
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant (NASDAQ: ROIV) CIO sells option shares near $37 - Stock Titan
ROIV Stock Nears Record High –Retail Traders See Breakout After Surprise Earnings Beat - Stocktwits
107,786 Shares in Roivant Sciences Ltd. $ROIV Purchased by Great Lakes Advisors LLC - MarketBeat
Is Roivant Sciences (ROIV) Fully Valued As First Quarter Results Show A Narrower Loss? - Sahm
Roivant Sciences (ROIV) holder plans new sale after $17M June trade - Stock Titan
Roivant Sciences Insider Sold Shares Worth $24,160,402, According to a Recent SEC Filing - marketscreener.com
Roivant President, CIO Mayukh Sukhatme disposes of USD 24.12 million in common shares - Bitget
Roivant Sciences (NASDAQ:ROIV) Insider Mayukh Sukhatme Sells 243,177 Shares - MarketBeat
Mayukh Sukhatme Sells 284,707 Shares of Roivant Sciences (NASDAQ:ROIV) Stock - MarketBeat
Roivant (ROIV) CIO sells shares after exercising $3.85 options - Stock Titan
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Roivant Sciences stock hits all-time high at 37.06 USD By Investing.com - Investing.com Australia
Roivant (NASDAQ: ROIV) holder eyes new sale after tens of millions sold - Stock Titan
Roivant Sciences (ROIV) Holds Steady at $36.2 as Shares Consolidate Between Support and ResistanceDefined Outcome ETF - vinanet.vn
Roivant Sciences (NASDAQ:ROIV) Sets New 1-Year HighHere's Why - MarketBeat
Roivant Sciences stock hits all-time high at 37.06 USD - Investing.com
Why Is Roivant (NASDAQ:ROIV) in NASDAQ Composite Focus Before Results? - Kalkine Media
Why Is Roivant (NASDAQ:ROIV) a Nasdaq Healthcare Stock to Watch? - Kalkine Media
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 15.52% Upside Potential with Strong Buy Ratings - DirectorsTalk Interviews
Roivant Sciences Ltd (ROIV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
How Investors May Respond To Roivant Sciences (ROIV) Narrowing Losses Despite Weaker Quarterly Revenue - simplywall.st
Royal Bank of Canada Decreases Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Empowered Funds LLC Buys 267,686 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Handelsbanken Fonder AB Has $6.27 Million Position in Roivant Sciences Ltd. $ROIV - MarketBeat
9 Health Care Stocks Whale Activity In Today’s Session - Benzinga
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
How Roivant Sciences Ltd. (ROIV) Affects Rotational Strategy Timing - Stock Traders Daily
Roivant Sciences Ltd. (ROIV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Roivant Sciences Ltd (ROIV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46 - Moomoo
Roivant Sciences (ROIV) Is Up 7.2% After Narrower Net Loss Despite Lower Quarterly Revenue - webull.com
J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings And 15% Upside Potential - DirectorsTalk Interviews
Is Roivant Sciences’ (ROIV) Cost Discipline Offsetting Slower Revenue Enough to Refresh Its Story? - Yahoo Finance
Is Roivant Sciences (ROIV) Overvalued On First Quarter Results? - Yahoo Finance
Bank of America Corp DE Has $87.64 Million Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences: The Balance Sheet Has Become A Strategic Weapon - Seeking Alpha
Sei Investments Co. Acquires 33,508 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV) Stock Rally Leans On Cash As Losses Persist - simplywall.st
Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Guggenheim Issues Positive Forecast for Roivant Sciences (NASDAQ:ROIV) Stock Price - MarketBeat
Roivant Sciences Ltd (ROIV) Stock News Today - TradingKey
Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $42 - Moomoo
Roivant Sciences Ltd. Q1 2026 Earnings Call Summary - finance.yahoo.com
Roivant Sciences Q1 Earnings Call Highlights - MarketBeat
Assenagon Asset Management S.A. Acquires 1,286,464 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
TD Cowen raises Roivant Sciences stock price target to $50 on execution - Investing.com South Africa
Roivant Sciences Ltd. Stock 12‑Month Price Target Raised to $39.73, Implies 15% Upside - TradingView
Earnings call transcript: Roivant posts Q1 2026 EPS beat, revenue miss as shares slip - Investing.com Nigeria
Roivant Sciences earnings beat by $0.04, revenue fell short of estimates - Investing.com
Roivant Sciences Releases Q1 2026 Financial Results - AlphaStreet
Roivant Sciences shares rise despite revenue miss - Investing.com
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Roivant Sciences Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
8.37%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):